Zoledronic acid is a type of bisphosphonate that is commonly used in the treatment of various bone diseases, including osteoporosis and Paget's disease. In the context of cancer, it is particularly effective in managing bone metastases and preventing skeletal-related events (SREs) in patients with cancers that have spread to the bone.
